Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
2 hedge funds and large institutions have $9K invested in Cellectar Biosciences, Inc. Series A Warrants in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
99% less capital invested
Capital invested by funds: $1.23M → $9K (-$1.23M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$5.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.23M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.63K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $8K | +$5.92K | +21,755 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$7.63K | -28,027 | -95% |
|
|
ACM
3
AIGH Capital Management
Baltimore,
Maryland
| – | -$1.23M | -583,037 | Closed |
|
|
TSS
4
Two Sigma Securities
New York
| – | -$2K | -14,221 | Closed |
|
CLRBZ Hedge Fund Activity: Q1 2021 in Review
2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q1 2021, worth a combined $9K — down 99% from $1.23M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CLRBZ and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $5.92K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.23M sold.
- 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q1 2021, down from 3 in Q4 2020.
- Funds reported $9K of Cellectar Biosciences, Inc. Series A Warrants stock for Q1 2021, down 99% quarter-over-quarter.
- 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q1 2021 and 2 closed out, a net change of -1 holder.
- The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q1 2021 was Virtu Financial, an estimated $5.92K added.
- The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q1 2021 was AIGH Capital Management, an estimated $1.23M sold.
Based on aggregated 13F filings for Q1 2021.